Catalyst Financial Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $858K | Sell |
7,991
-78
| -1% | -$8.38K | 0.09% | 96 |
|
|
2025
Q1 | $814K | Buy |
8,069
+942
| +13% | +$95K | 0.15% | 85 |
|
|
2024
Q4 | $637K | Buy |
7,127
+154
| +2% | +$13.8K | 0.12% | 107 |
|
|
2024
Q3 | $584K | Sell |
6,973
-62
| -0.9% | -$5.2K | 0.11% | 120 |
|
|
2024
Q2 | $542K | Buy |
7,035
+738
| +12% | +$56.8K | 0.12% | 113 |
|
|
2024
Q1 | $428K | Buy |
6,297
+683
| +12% | +$46.4K | 0.11% | 129 |
|
|
2023
Q4 | $325K | Buy |
5,614
+270
| +5% | +$15.6K | 0.09% | 153 |
|
|
2023
Q3 | $282K | Buy |
5,344
+307
| +6% | +$16.2K | 0.09% | 162 |
|
|
2023
Q2 | $272K | Buy |
5,037
+57
| +1% | +$3.08K | 0.1% | 153 |
|
|
2023
Q1 | $249K | Sell |
4,980
-80
| -2% | -$4K | 0.11% | 144 |
|
|
2022
Q4 | $234K | Buy |
+5,060
| New | +$234K | 0.12% | 142 |
|